Carrie E. Carlander McQueen
Director/Board Member at Forest Home Foundation
Carrie E. Carlander McQueen active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Forest Home Foundation | Director/Board Member | - | - |
Career history of Carrie E. Carlander McQueen
Former positions of Carrie E. Carlander McQueen
| Companies | Position | Start | End |
|---|---|---|---|
| LIFEVANTAGE CORPORATION | Director/Board Member | 2009-06-06 | 2012-02-06 |
| Director of Finance/CFO | 2009-06-06 | 2012-07-31 | |
| Corporate Secretary | 2009-06-06 | 2012-05-31 | |
| Treasurer | 2009-06-06 | 2012-07-31 | |
Mast Therapeutics, Inc.
 Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Director of Finance/CFO | - | 2006-09-04 |
| Treasurer | - | 2006-09-04 | |
| SRAX, INC. | Comptroller/Controller/Auditor | 2014-11-04 | - |
| Director of Finance/CFO | 2014-11-04 | 2016-04-12 |
Training of Carrie E. Carlander McQueen
| San Diego State University | Masters Business Admin |
| University of California San Diego | Undergraduate Degree |
Statistics
International
| United States | 7 |
Operational
| Director of Finance/CFO | 3 |
| Treasurer | 2 |
| Director/Board Member | 2 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Technology Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| LIFEVANTAGE CORPORATION | Health Technology |
| SRAX, INC. | Technology Services |
| Private companies | 2 |
|---|---|
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Health Technology |
| Forest Home Foundation |
